Skip to main content
. 2021 Apr;12(Suppl 1):S242–S258. doi: 10.21037/jgo-20-257

Table 7. Macroscopic response.

Studies CRC patients Evaluated patients Total PIPAC-OX Response assessment
Progressive Stable Regressive
Ellebæk [2020] (17) 24 7 75 ns ns 3
Willaert [2019] (18) 15 7 45 3 0 4

CRC, colorectal cancer; PIPAC-OX, pressurized intraperitoneal aerosol chemotherapy with oxaliplatin; ns, not shown.